The Cigna Group
CI: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$151.00 | Kyhgx | Slwbpjyn |
As Cigna Posts Strong 2Q, Fair Value Unchanged
Narrow-moat Cigna turned in strong second-quarter operating results that allowed management to boost its 2022 outlook a bit. Even after incorporating these mildly stronger near-term expectations, our $299 fair value estimate has not changed materially. Shares appear to be moving closer to fair value due to the company's operational momentum.